CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 24, 2022 · earnings

KYMR earnings: a positive outcome, +9.4%

On February 24, 2022, Kymera Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.4% in the window around the event.

The move

$35.96
1d before
$39.34
Event day
$40.07
1d after
$38.53
5d after

Pre-catalyst setup

-2.4%
30-day run-up
8018%
30-day volatility
0.8×
volume spike